Consulta Ltd buys $81,631,000 stake in DaVita HealthCare Partners Inc (DVA)

DaVita HealthCare Partners Inc (DVA) : Consulta Ltd scooped up 350,000 additional shares in DaVita HealthCare Partners Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Apr 12, 2016. The investment management firm now holds a total of 1,100,000 shares of DaVita HealthCare Partners Inc which is valued at $81,631,000.DaVita HealthCare Partners Inc makes up approximately 9.89% of Consulta Ltd’s portfolio.

DaVita HealthCare Partners Inc opened for trading at $74.17 and hit $74.48 on the upside on Friday, eventually ending the session at $74.21, with a gain of 0.01% or 0.01 points. The heightened volatility saw the trading volume jump to 6,26,749 shares. Company has a market cap of $15,295 M.

Other Hedge Funds, Including , Norman Fields Gottscho Capital Management boosted its stake in DVA in the latest quarter, The investment management firm added 55,675 additional shares and now holds a total of 86,727 shares of DaVita HealthCare Partners Inc which is valued at $6,436,011. DaVita HealthCare Partners Inc makes up approx 4.26% of Norman Fields Gottscho Capital Management’s portfolio.Central Trust Co reduced its stake in DVA by selling 400 shares or 15.66% in the most recent quarter. The Hedge Fund company now holds 2,154 shares of DVA which is valued at $159,848. DaVita HealthCare Partners Inc makes up approx 0.01% of Central Trust Co’s portfolio.Rathbone Brothers Plc reduced its stake in DVA by selling 900 shares or 14.81% in the most recent quarter. The Hedge Fund company now holds 5,175 shares of DVA which is valued at $379,949. DaVita HealthCare Partners Inc makes up approx 0.02% of Rathbone Brothers Plc’s portfolio.Pensionfund Sabic boosted its stake in DVA in the latest quarter, The investment management firm added 1,500 additional shares and now holds a total of 20,500 shares of DaVita HealthCare Partners Inc which is valued at $1,505,110. DaVita HealthCare Partners Inc makes up approx 0.46% of Pensionfund Sabic’s portfolio.

On the company’s financial health, DaVita HealthCare Partners Inc reported $1.12 EPS for the quarter, beating the analyst consensus estimate by $ 0.15 according to the earnings call on Feb 11, 2016. Analyst had a consensus of $0.97. The company had revenue of $3533.60 million for the quarter, compared to analysts expectations of $3499.65 million. The company’s revenue was up 6.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.09 EPS.

Many Wall Street Analysts have commented on DaVita HealthCare Partners Inc. Shares were Reiterated by RBC Capital Mkts on Feb 16, 2016 to “Sector Perform” and Lowered the Price Target to $ 71 from a previous price target of $80 .

DaVita HealthCare Partners Inc. consists of two divisions Kidney Care and HealthCare Partners (HCP). Kidney Care is a provider of dialysis services in the United States treating patients with chronic kidney failure and end stage renal disease (ESRD). Kidney Care division develops innovative clinical care offers integrated treatment plans personalized care teams and health-management services. As of December 31 2014 we provided dialysis and administrative services in the U.S. through a network of 2179 outpatient dialysis centers in 46 states and the District of Columbia serving a total of approximately 173000 patients. HealthCare Partners division is a patient- and physician-focused integrated health care delivery and management company. HealthCare Partners manages and operates medical groups and affiliated physician networks in Arizona California Nevada Florida and New Mexico. As of December 2014 HealthCare Partners had approximately 837000 members under its care.

Leave a Reply

DaVita HealthCare Partners Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on DaVita HealthCare Partners Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.